Kepos Capital LP Aldeyra Therapeutics, Inc. Transaction History

Kepos Capital LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$1.62 - $6.4 $116,981 - $462,150	-72,211 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$4.73 - $7.98 $184,044 - $310,501	38,910 Added 116.84%	72,211 $420,000
Q1 2019 May 13, 2019	SELL	$7.14 - $9.85 $476,230 - $656,985	-66,699 Reduced 66.7%	33,301 $301,000
Q4 2018 Feb 13, 2019	SELL	$7.26 - $13.29 $645,051 - $1.18 Million	-88,850 Reduced 47.05%	100,000 $830,000
Q2 2018 Aug 13, 2018	BUY	$6.95 - $9.18 $1.31 Million - $1.73 Million	188,850 New	188,850 $1.5 Million

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $280M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.